Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
semaglutide
Pharma
Novo Nordisk's Ozempic excels in diabetes, kidney disease trial
A trial of Novo Nordisk's Ozempic on diabetes and kidney disease patients found that it reduced the risk of disease progression and death by 24%.
Kevin Dunleavy
Mar 5, 2024 11:39am
The FDA cracks down with a trio of pharma warning letters
Feb 14, 2024 8:15am
Study says no link with Novo’s GLP-1 drugs and suicidal ideation
Jan 5, 2024 11:14am
FDA examining side-effect reports with Lilly, Novo obesity drugs
Jan 4, 2024 11:33am
BMJ probe questions oversight of UK pharmacy materials on Wegovy
Dec 13, 2023 6:30pm
FDA warns of unapproved versions of Wegovy and Mounjaro
Oct 11, 2023 9:50am